Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care
Recruiting now
Conditions studied: Heart Failure
In brief
The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the study will be used to monitor changes in the patient's standard of care throughout the study period and gather patient perspectives on routine diagnostic procedures and disease monitoring and feedback on the design of heart failure trials.
Key facts
- Study ID
- NCT06809686
- Run by
- Richmond Research Institute
- People needed
- 1000
- Starts
- 2025-02-05
- Expected to finish
- 2027-02-21
- Last updated by the study team
- 2026-05-20
Who can join
Age: 45 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female participants aged 45 to 80 years (inclusive) at the date of signing the informed consent.
- Diagnosed with heart failure.
- Able and willing to provide informed consent to participate.
You may not qualify if…
- Diagnostic test results positive for:
- HIV-1 or HIV-2 infection
- Hepatitis B or Hepatitis C infection
- Mental incapacity, language barriers or unwillingness to comply with the requirements of the protocol, which may preclude adequate understanding or cooperation during the study as judged by the Investigator.
- Any condition judged by the Investigator to pose an undue risk while participating in the trial
- Diagnostic results which are inconsistent with heart failure with mildly reduced or preserved ejection fraction as judged by the Investigator.
Where it is running
- Richmond Pharmacology — London, London, United Kingdom (enrolling)
- Richmond Pharmacology — London, London, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.